238 related articles for article (PubMed ID: 23091298)
21. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.
Robaina MC; Faccion RS; Mazzoccoli L; Rezende LM; Queiroga E; Bacchi CE; Thomas-Tikhonenko A; Klumb CE
Ann Hematol; 2016 May; 95(6):881-91. PubMed ID: 27044389
[TBL] [Abstract][Full Text] [Related]
22. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma.
Seitz V; Butzhammer P; Hirsch B; Hecht J; Gütgemann I; Ehlers A; Lenze D; Oker E; Sommerfeld A; von der Wall E; König C; Zinser C; Spang R; Hummel M
PLoS One; 2011; 6(11):e26837. PubMed ID: 22102868
[TBL] [Abstract][Full Text] [Related]
23. Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling.
Deffenbacher KE; Iqbal J; Sanger W; Shen Y; Lachel C; Liu Z; Liu Y; Lim MS; Perkins SL; Fu K; Smith L; Lynch J; Staudt LM; Rimsza LM; Jaffe E; Rosenwald A; Ott GK; Delabie J; Campo E; Gascoyne RD; Cairo MS; Weisenburger DD; Greiner TC; Gross TG; Chan WC
Blood; 2012 Apr; 119(16):3757-66. PubMed ID: 22374697
[TBL] [Abstract][Full Text] [Related]
24. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.
López C; Kleinheinz K; Aukema SM; Rohde M; Bernhart SH; Hübschmann D; Wagener R; Toprak UH; Raimondi F; Kreuz M; Waszak SM; Huang Z; Sieverling L; Paramasivam N; Seufert J; Sungalee S; Russell RB; Bausinger J; Kretzmer H; Ammerpohl O; Bergmann AK; Binder H; Borkhardt A; Brors B; Claviez A; Doose G; Feuerbach L; Haake A; Hansmann ML; Hoell J; Hummel M; Korbel JO; Lawerenz C; Lenze D; Radlwimmer B; Richter J; Rosenstiel P; Rosenwald A; Schilhabel MB; Stein H; Stilgenbauer S; Stadler PF; Szczepanowski M; Weniger MA; Zapatka M; Eils R; Lichter P; Loeffler M; Möller P; Trümper L; Klapper W; ; Hoffmann S; Küppers R; Burkhardt B; Schlesner M; Siebert R
Nat Commun; 2019 Mar; 10(1):1459. PubMed ID: 30926794
[TBL] [Abstract][Full Text] [Related]
25. [Mutations in histone H3.3 and chromatin remodeling genes drive pediatric and young adult glioblastomas].
Khuong-Quang DA; Gerges N; Jabado N
Med Sci (Paris); 2012 Oct; 28(10):809-12. PubMed ID: 23067407
[No Abstract] [Full Text] [Related]
26. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
[TBL] [Abstract][Full Text] [Related]
27. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.
Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH
Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030
[TBL] [Abstract][Full Text] [Related]
28. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.
Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM
Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998
[TBL] [Abstract][Full Text] [Related]
29. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.
De Falco G; Leucci E; Lenze D; Piccaluga PP; Claudio PP; Onnis A; Cerino G; Nyagol J; Mwanda W; Bellan C; Hummel M; Pileri S; Tosi P; Stein H; Giordano A; Leoncini L
Blood; 2007 Aug; 110(4):1301-7. PubMed ID: 17485552
[TBL] [Abstract][Full Text] [Related]
30. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ
Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
[TBL] [Abstract][Full Text] [Related]
32. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
Amato T; Abate F; Piccaluga P; Iacono M; Fallerini C; Renieri A; De Falco G; Ambrosio MR; Mourmouras V; Ogwang M; Calbi V; Rabadan R; Hummel M; Pileri S; Leoncini L; Bellan C
Am J Clin Pathol; 2016 Jan; 145(1):116-27. PubMed ID: 26712879
[TBL] [Abstract][Full Text] [Related]
33. Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.
Rohde M; Richter J; Schlesner M; Betts MJ; Claviez A; Bonn BR; Zimmermann M; Damm-Welk C; Russell RB; Borkhardt A; Eils R; Hoell JI; Szczepanowski M; Oschlies I; Klapper W; Burkhardt B; Siebert R; ;
Genes Chromosomes Cancer; 2014 Nov; 53(11):911-6. PubMed ID: 25044415
[TBL] [Abstract][Full Text] [Related]
34. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
Zang ZJ; Cutcutache I; Poon SL; Zhang SL; McPherson JR; Tao J; Rajasegaran V; Heng HL; Deng N; Gan A; Lim KH; Ong CK; Huang D; Chin SY; Tan IB; Ng CC; Yu W; Wu Y; Lee M; Wu J; Poh D; Wan WK; Rha SY; So J; Salto-Tellez M; Yeoh KG; Wong WK; Zhu YJ; Futreal PA; Pang B; Ruan Y; Hillmer AM; Bertrand D; Nagarajan N; Rozen S; Teh BT; Tan P
Nat Genet; 2012 May; 44(5):570-4. PubMed ID: 22484628
[TBL] [Abstract][Full Text] [Related]
35. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
[TBL] [Abstract][Full Text] [Related]
36. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
[TBL] [Abstract][Full Text] [Related]
37. Genomics of aggressive B-cell lymphoma.
Rosenthal A; Rimsza L
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):69-74. PubMed ID: 30504293
[TBL] [Abstract][Full Text] [Related]
38. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
39. Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.
Shain AH; Giacomini CP; Matsukuma K; Karikari CA; Bashyam MD; Hidalgo M; Maitra A; Pollack JR
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):E252-9. PubMed ID: 22233809
[TBL] [Abstract][Full Text] [Related]
40. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
